Role of IBD Nurse and Advanced Practice Provider

08/02/2018

Related Content

Gastroenterology

Gastroenterology

De-escalation strategies in IBD: Are we ready for this?

08/07/2018

Multiple Sclerosis

Laura Safar, MD, on Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Key Clinical Takeaways

08/24/2017

In this video, Laura T. Safar, MD, addresses the impact of neuropsychiatric disorders on quality of life among patients with multiple sclerosis, and the importance of monitoring the prevalence of...

08/24/2017

Gastroenterology

Gastroenterology

Contraceptive and Reproductive Planning in Women IBD

08/17/2018

Psoriatic Arthritis

Gurjit S. Kaeley, MD, on Enthesitis in Psoriatic Arthritis

07/14/2019

In this video, Gurjit S. Kaeley, MD, from the University of Florida, discusses the importance of evaluating enthesitis in individuals with psoriatic arthritis, and more.

07/14/2019

Gastroenterology

Positioning of Biologics in the Clinic

08/16/2018

Current Consultant Issue

Previous Issues

Early View

Research Summaries

Research Summary

Research Summary

Phase 3 ROSELLA Shows OS Gain in Platinum-Resistant Ovarian Cancer

05/14/2026

Ashton L. Stahl

Phase 3 data evaluated whether relacorilant plus nab-paclitaxel improves survival in platinum-resistant ovarian cancer.

05/14/2026

Long COVID Roundup

Long COVID Roundup

Studies Associate Long COVID With Cognitive, Neurologic, and Academic Outcomes

05/14/2026

Anthony Calabro, MA

Recent studies in children and adults associate long COVID with worsened academic performance, attention difficulties, subjective cognitive impairment, and persistent neurologic and psychiatric symptoms. ...

05/14/2026

Research Summary

Research Summary

Phase 2 MRD-Driven Acalabrutinib Triplets Show Molecular Complete Responses in Frontline MCL

05/14/2026

Anthony Calabro, MA

In an open-label, multicenter phase 2 study, frontline mantle cell lymphoma, MRD-driven acalabrutinib-lenalidomide anti-CD20 therapy produced high molecular complete response rates.

05/14/2026

Research Summary

doctor with clipboard talking to patient

Research Summary

Phase 1/2 BRUIN: Pirtobrutinib Maintains Patient-Reported Outcomes in CLL/SLL and MCL

05/14/2026

Anthony Calabro, MA

In phase 1/2 BRUIN, most patients with CLL/SLL or MCL had stable or improved PROs during pirtobrutinib treatment.

05/14/2026

FDA Approval

FDA Approval

FDA Grants Accelerated Approval to Sonrotoclax (Beqalzi) for Relapsed or Refractory MCL

05/14/2026

Ashton L. Stahl

The FDA has approved sonrotoclax for adults with relapsed or refractory mantle cell lymphoma who have received prior BTK inhibitor therapy.

05/14/2026

Trending Articles

Disease State Pillar

Disease State Pillar

HIV Management: A Practical Guide for Primary Care

12/09/2025

With modern antiretroviral therapy (ART), human immunodeficiency virus (HIV) is a chronic, manageable condition—but outcomes hinge on rapid treatment start, durable viral suppression, and proactive primary...

12/09/2025

Disease State Pillar

Disease State Pillar

Chronic Obstructive Pulmonary Disease: A Comprehensive Guide for Primary Care

11/05/2025

What is COPD? Chronic obstructive pulmonary disease (COPD) is a progressive, preventable condition marked by airflow limitation and respiratory symptoms such as dyspnea, chronic cough, and sputum...

11/05/2025

Disease State Pillar

Disease State Pillar

Agitation in Alzheimer Disease: A Comprehensive Guide for Primary Care

09/08/2025

Agitation is a common and challenging behavioral symptom in dementia that primary care providers frequently encounter. Characterized by increased motor activity, restlessness, verbal or physical aggression,...

09/08/2025

Slideshow

Slideshow

Consultant360’s Summer Playlist: Expert Perspectives on Emerging Clinical Issues

09/15/2025

This summer, Consultant360 brought you thought-provoking conversations with leading clinicians on some of the most pressing issues in patient care—from the latest Advisory Committee on Immunization...

09/15/2025

Meeting Coverage

Meeting Coverage

What Clinicians Need to Know About ACIP’s June 2025 Meeting

09/26/2025

Key Highlights Clesrovimab approved for infants under 8 months to prevent respiratory syncytial virus during their first season, and added to the Vaccines for Children program for free access. FluMist...

09/26/2025